Background Differentiated thyroid cancer (DTC) work-up is based on (near) total- thyroidectomy plus thyroid remnant ablation (TRA) with 131-radioiodine in many patients …
A Campennì, M Siracusa, RM Ruggeri, R Laudicella… - Scientific reports, 2017 - nature.com
Quantitative 99mTc-MIBI thyroid scintigraphy is a useful tool in differentiating malignant from benign thyroid nodules with indeterminate cytology. The aim of our report is to compare the …
A Campennì, RM Ruggeri, M Siracusa… - European Journal of …, 2021 - academic.oup.com
Aim The risk of differentiated thyroid cancer (DTC) recurrence is widely evaluated according to the 2015 ATA Risk Stratification System. Topography of malignant nodules has been …
A Campennì, L Giovanella, M Siracusa, ME Stipo… - Thyroid, 2014 - liebertpub.com
Background: Differentiated thyroid cancer (DTC) is the most common endocrine malignancy. In recent decades, the incidence has been increasing, largely due to increased detection of …
BC Ahn, SW Lee, J Lee, C Kim - Thyroid, 2011 - liebertpub.com
Background: Whole-body scans (WBSs) based on diagnostic or therapeutic doses of I-131 can visualize metastatic lesions in thyroid cancer patients who have undergone total …
EO Onkendi, ML Richards, GB Thompson… - Annals of surgical …, 2012 - Springer
Background Thyroid cancer cells have been shown to take up 99m Tc-sestamibi. The role for 99m Tc-sestamibi scintigraphy (Tc-MIBI) in the diagnosis of thyroid cancer in patients with …
F Galli, I Manni, G Piaggio, L Balogh, BD Weintraub… - Thyroid, 2014 - liebertpub.com
Background: Differentiated thyroid carcinomas originating from thyroid follicular cells are frequent tumors of the thyroid with relatively good prognosis due to improved surgical …